Mapping of molecular pathways, biomarkers and drug targets for diabetic nephropathy

Abstract

Only the combined molecular feature landscapes closely reflect the clinical implications of DN in the context of hypertension and diabetes. Omics data integration on the level of interaction networks furthermore provides a platform for identification of pathway-specific biomarkers and therapy options.